References
- World Health Organization. Cancer today, Estimated number of new cases in 2020, leukemia, both sexes, ages 0–19. . 2023; Available from:
https://gco.iarc.fr/today/online-analysis-pie?v=2020&mode=population&mode_population=who&population=900&populations=900&key=total&sex=0&cancer=36&type=0&statistic=5&prevalence=0&population_group=2&ages_group%5B%5D=0&ages_group%5B%5D=3&nb_items=7&group_cancer=1&include_nmsc=1&include_nmsc_other=1&population_group_list=32,44,52,84,68,76,152,170,188,192,214,218,222,312,474,254,320,328,332,340,388,484,558,591,600,604,630,662,740,780,858,862&half_pie=0&donut=0&population_group_globocan_id=904 . - Matysiak M. Białaczki u dzieci. Pediatria po dyplomie. 2014; 18: 23–26
- Malard F, Mohty M. Acute lymphoblastic leukaemia. Lancet. 2020; 395: 1146–1162
- Terwilliger T, Abdul-Hay M. Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer J. 2017; 7: e577
- Metayer C, Milne E, Clavel J, Infante-Rivard C, Petridou E, Taylor M, Schuz J, Spector LG, Dockerty JD, Magnani C, et al. The Childhood Leukemia International Consortium. Cancer Epidemiol. 2013; 37: 336–347
- Duffield AS, Mullighan CG, Borowitz MJ. International Consensus Classification of acute lymphoblastic leukemia/lymphoma. Virchows Arch. 2023; 482: 11–26
- Puumala SE, Ross JA, Aplenc R, Spector LG. Epidemiology of childhood acute myeloid leukemia. Pediatr Blood Cancer. 2013; 60: 728–733
- Cheng J, Sakamot KM. Topics in pediatric leukemia--acute myeloid leukemia. MedGenMed. 2005; 7: 20
- Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka HM, Wang SA, Bagg A, Barbui T, Branford S, et al. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022; 140: 1200–1228
- World Health Organization. Cancer today, Estimated number of new deaths in 2020, leukemia, both sexes, ages 0–19. 2020; Available from:
https://gco.iarc.fr/today/online-analysis-pie?v=2020&mode=population&mode_population=who&population=900&populations=900&key=total&sex=0&cancer=36&type=1&statistic=5&prevalence=0&population_group=2&ages_group%5B%5D=0&ages_group%5B%5D=3&nb_items=7&group_cancer=1&include_nmsc=1&include_nmsc_other=1&population_group_list=32,44,52,84,68,76,152,170,188,192,214,218,222,312,474,254,320,328,332,340,388,484,558,591,600,604,630,662,740,780,858,862&half_pie=0&donut=0&population_group_globocan_id=904 . - Tai EW, Ward KC, Bonaventure A, Siegel DA, Coleman MP. Survival among children diagnosed with acute lymphoblastic leukemia in the United States, by race and age, 2001 to 2009: Findings from the CONCORD-2 study. Cancer. 2017; 123 Suppl 24: 5178–5189
- Seksarn P, Wiangnon S, Veerakul G, Chotsampancharoen T, Kanjanapongkul S, Chainansamit SO. Outcome of Childhood Acute Lymphoblastic Leukemia Treated Using the Thai National Protocols. Asian Pac J Cancer Prev. 2015; 16: 4609–4614
- Demidowicz E, Pogorzala M, Lecka M, Zolnowska H, Marjanska A, Kubicka M, Kurylo-Rafinska B, Czyzewski K, Debski R, Koltan A, et al. Outcome of Pediatric Acute Lymphoblastic Leukemia: Sixty Years of Progress. Anticancer Res. 2019; 39: 5203–5207
- Pui CH, Carroll WL, Meshinchi S, Arceci RJ. Biology, risk stratification, and therapy of pediatric acute leukemias: an update. J Clin Oncol. 2011; 29: 551–565
- Balwierz W, Pawinska-Wasikowska K, Klekawka T, Czogala M, Matysiak M, Fic-Sikorska B, Adamkiewicz-Drozynska E, Maciejka-Kapuscinska L, Chybicka A, Potocka K, et al. Development of treatment and clinical results in childhood acute myeloid leukemia in Poland. Memo. 2013; 6: 54–62
- World Health Organization. Cancer tomorrow, Changes of new cases from 2020 to 2030. 2023; Available from:
https://gco.iarc.fr/tomorrow/en/dataviz/bars?age_end=3&bar_mode=grouped&cancers=36&group_cancers=0&multiple_cancers=0&group_populations=0&populations=991_992_993_994_995_996&key=percent&show_bar_mode_prop=0&years=2030&types=0 . - National Cancer Institute. Surveillance, Epidemiology, and End Results Program, SEER Incidence Rates by Age at Diagnosis, 2016–2020, ages 0–19. 2023; Available from:
https://seer.cancer.gov/statistics-network/explorer/application.html?site=92&data_type=1&graph_type=3&compareBy=sex&chk_sex_1=1&hdn_rate_type=1&race=1&advopt_precision=1&advopt_show_ci=on&advopt_show_count=on&hdn_view=1#resultsRegion1 . - Hossain MJ, Xie L, McCahan SM. Characterization of pediatric acute lymphoblastic leukemia survival patterns by age at diagnosis. J Cancer Epidemiol. 2014; 2014: 865979
- Wang Y, Huang J, Rong L, Wu P, Kang M, Zhang X, Lu Q, Fang Y. Impact of age on the survival of pediatric leukemia: an analysis of 15083 children in the SEER database. Oncotarget. 2016; 7: 83767–83774
- World Health Organization. Cancer today, Estimated number of new cases in 2020, leukemia, famales, ages 0–19. 2023; Available from:
https://gco.iarc.fr/today/online-analysis-pie?v=2020&mode=population&mode_population=who&population=900&populations=900&key=total&sex=2&cancer=36&type=0&statistic=5&prevalence=0&population_group=2&ages_group%5B%5D=0&ages_group%5B%5D=3&nb_items=7&group_cancer=1&include_nmsc=1&include_nmsc_other=1&population_group_list=32,44,52,84,68,76,152,170,188,192,214,218,222,312,474,254,320,328,332,340,388,484,558,591,600,604,630,662,740,780,858,862&half_pie=0&donut=0&population_group_globocan_id=904 . - World Health Organization. Cancer today, Estimated number of new cases in 2020, leukemia, males, ages 0–19. 2023; Available from:
https://gco.iarc.fr/today/online-analysis-pie?v=2020&mode=population&mode_population=who&population=900&populations=900&key=total&sex=1&cancer=36&type=0&statistic=5&prevalence=0&population_group=2&ages_group%5B%5D=0&ages_group%5B%5D=3&nb_items=7&group_cancer=1&include_nmsc=1&include_nmsc_other=1&population_group_list=32,44,52,84,68,76,152,170,188,192,214,218,222,312,474,254,320,328,332,340,388,484,558,591,600,604,630,662,740,780,858,862&half_pie=0&donut=0&population_group_globocan_id=904 . - Kakaje A, Alhalabi MM, Ghareeb A, Karam B, Mansour B, Zahra B, Hamdan O. Rates and trends of childhood acute lymphoblastic leukaemia: an epidemiology study. Sci Rep. 2020; 10: 6756
- Jaime-Perez JC, Santos J, Gomez-Almaguer D. Childhood T-cell acute lymphoblastic leukemia in a single Latin American center: impact of improved treatment scheme and support therapy on survival. Hematol Transfus Cell Ther. 2020; 42: 320–325
- Singh SK, Lupo PJ, Scheurer ME, Saxena A, Kennedy AE, Ibrahimou B, Barbieri MA, Mills KI, McCauley JL, Okcu MF, et al. A childhood acute lymphoblastic leukemia genome-wide association study identifies novel sex-specific risk variants. Medicine (Baltimore). 2016; 95: e5300
- Zhao Y, Wang Y, Ma S. Racial Differences in Four Leukemia Subtypes: Comprehensive Descriptive Epidemiology. Sci Rep. 2018; 8: 548
- Oksuzyan S, Crespi CM, Cockburn M, Mezei G, Vergara X, Kheifets L. Race/ethnicity and the risk of childhood leukaemia: a case-control study in California. J Epidemiol Community Health. 2015; 69: 795–802
- Byrne MM, Halman LJ, Koniaris LG, Cassileth PA, Rosenblatt JD, Cheung MC. Effects of poverty and race on outcomes in acute myeloid leukemia. Am J Clin Oncol. 2011; 34: 297–304
- Qian M, Xu H, Perez-Andreu V, Roberts KG, Zhang H, Yang W, Zhang S, Zhao X, Smith C, Devidas M, et al. Novel susceptibility variants at the ERG locus for childhood acute lymphoblastic leukemia in Hispanics. Blood. 2019; 133: 724–729
- Chokkalingam AP, Hsu LI, Metayer C, Hansen HM, Month SR, Barcellos LF, Wiemels JL, Buffler PA. Genetic variants in ARID5B and CEBPE are childhood ALL susceptibility loci in Hispanics. Cancer Causes Control. 2013; 24: 1789–1795
- Rosenbaum PF, Buck GM, Brecher ML. Allergy and infectious disease histories and the risk of childhood acute lymphoblastic leukaemia. Paediatr Perinat Epidemiol. 2005; 19: 152–164
- Mullighan CG. The genomic landscape of acute lymphoblastic leukemia in children and young adults. Hematology Am Soc Hematol Educ Program. 2014; 2014: 174–180
- Folley JH, Borges W, Yamawaki T. Incidence of leukemia in survivors of the atomic bomb in Hiroshima and Nagasaki, Japan. Am J Med. 1952; 13: 311–321
- Abiri B, Kelishadi R, Sadeghi H, Azizi-Soleiman F. Effects of Maternal Diet During Pregnancy on the Risk of Childhood Acute Lymphoblastic Leukemia: A Systematic Review. Nutr Cancer. 2016; 68: 1065–1072
- Haddy N, Le Deley MC, Samand A, Diallo I, Guerin S, Guibout C, Oberlin O, Hawkins M, Zucker JM, de Vathaire F. Role of radiotherapy and chemotherapy in the risk of secondary leukaemia after a solid tumour in childhood. Eur J Cancer. 2006; 42: 2757–2764
- Nino G, Rodriguez-Martinez CE, Gutierrez MJ. Early Microbial-Immune Interactions and Innate Immune Training of the Respiratory System during Health and Disease. Children (Basel). 2021; 8:
- Simon AK, Hollander GA, McMichael A. Evolution of the immune system in humans from infancy to old age. Proc Biol Sci. 2015; 282: 20143085
- Greaves MF. Speculations on the cause of childhood acute lymphoblastic leukemia. Leukemia. 1988; 2: 120–125
- Alexander FE, Chan LC, Lam TH, Yuen P, Leung NK, Ha SY, Yuen HL, Li CK, Lau YL, Greaves MF. Clustering of childhood leukaemia in Hong Kong: association with the childhood peak and common acute lymphoblastic leukaemia and with population mixing. Br J Cancer. 1997; 75: 457–463
- Greaves M. A causal mechanism for childhood acute lymphoblastic leukaemia. Nat Rev Cancer. 2018; 18: 471–484
- Urayama KY, Ma X, Selvin S, Metayer C, Chokkalingam AP, Wiemels JL, Does M, Chang J, Wong A, Trachtenberg E, et al. Early life exposure to infections and risk of childhood acute lymphoblastic leukemia. Int J Cancer. 2011; 128: 1632–1643
- Urayama KY, Buffler PA, Gallagher ER, Ayoob JM, Ma X. A meta-analysis of the association between day-care attendance and childhood acute lymphoblastic leukaemia. Int J Epidemiol. 2010; 39: 718–732
- Gilham C, Peto J, Simpson J, Roman E, Eden TO, Greaves MF, Alexander FE. Day care in infancy and risk of childhood acute lymphoblastic leukaemia: findings from UK case-control study. BMJ. 2005; 330: 1294
- Kinlen LJ. Epidemiological evidence for an infective basis in childhood leukaemia. Br J Cancer. 1995; 71: 1–5
- Smith M. Considerations on a possible viral etiology for B-precursor acute lymphoblastic leukemia of childhood. J Immunother. 1997; 20: 89–100
- Tedeschi R, Bloigu A, Ogmundsdottir HM, Marus A, Dillner J, dePaoli P, Gudnadottir M, Koskela P, Pukkala E, Lehtinen T, et al. Activation of maternal Epstein-Barr virus infection and risk of acute leukemia in the offspring. Am J Epidemiol. 2007; 165: 134–137
- Kwan ML, Metayer C, Crouse V, Buffler PA. Maternal illness and drug/medication use during the period surrounding pregnancy and risk of childhood leukemia among offspring. Am J Epidemiol. 2007; 165: 27–35
- Jourdan-Da Silva N, Perel Y, Mechinaud F, Plouvier E, Gandemer V, Lutz P, Vannier JP, Lamagnere JL, Margueritte G, Boutard P, et al. Infectious diseases in the first year of life, perinatal characteristics and childhood acute leukaemia. Br J Cancer. 2004; 90: 139–145
- Randolph VL, Heath CW, Jr. Influenza during pregnancy in relation to subsequent childhood leukemia and lymphoma. Am J Epidemiol. 1974; 100: 399–409
- Kinlen LJ. Infection and childhood leukemia. Cancer Causes Control. 1998; 9: 237–239
- Wartenberg D, Schneider D, Brown S. Childhood leukaemia incidence and the population mixing hypothesis in US SEER data. Br J Cancer. 2004; 90: 1771–1776
- Clark BR, Ferketich AK, Fisher JL, Ruymann FB, Harris RE, Wilkins JR, 3rd. Evidence of population mixing based on the geographical distribution of childhood leukemia in Ohio. Pediatr Blood Cancer. 2007; 49: 797–802
- Orem J, Mbidde EK, Lambert B, de Sanjose S, Weiderpass E. Burkitt’s lymphoma in Africa, a review of the epidemiology and etiology. Afr Health Sci. 2007; 7: 166–175
- Guan H, Miao H, Ma N, Lu W, Luo B. Correlations between Epstein-Barr virus and acute leukemia. J Med Virol. 2017; 89: 1453–1460
- Telford M, Navarro A, Santpere G. Whole genome diversity of inherited chromosomally integrated HHV-6 derived from healthy individuals of diverse geographic origin. Sci Rep. 2018; 8: 3472
- Luka J, Pirruccello SJ, Kersey JH. HHV-6 genome in T-cell acute lymphoblastic leukaemia. Lancet. 1991; 338: 1277–1278
- Hermouet S, Sutton CA, Rose TM, Greenblatt RJ, Corre I, Garand R, Neves AM, Bataille R, Casey JW. Qualitative and quantitative analysis of human herpesviruses in chronic and acute B cell lymphocytic leukemia and in multiple myeloma. Leukemia. 2003; 17: 185–195
- Salonen MJ, Siimes MA, Salonen EM, Vaheri A, Koskiniemi M. Antibody status to HHV-6 in children with leukaemia. Leukemia. 2002; 16: 716–719
- Tirado-Rodriguez B, Huerta-Yepez S. Allergies: diseases closely related to cancer. Bol Med Hosp Infant Mex. 2016; 73: 432–445
- Schuz J, Morgan G, Bohler E, Kaatsch P, Michaelis J. Atopic disease and childhood acute lymphoblastic leukemia. Int J Cancer. 2003; 105: 255–260
- Chang JS, Tsai YW, Tsai CR, Wiemels JL. Allergy and risk of childhood acute lymphoblastic leukemia: a population-based and record-based study. Am J Epidemiol. 2012; 176: 970–978
- Chang JS, Zhou M, Buffler PA, Chokkalingam AP, Metayer C, Wiemels JL. Profound deficit of IL10 at birth in children who develop childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev. 2011; 20: 1736–1740
- Chang JS, Buffler PA, Metayer C, Chokkalingam AP, Patoka J, Kronish D, Wiemels JL. Maternal immunoglobulin E and childhood leukemia. Cancer Epidemiol Biomarkers Prev. 2009; 18: 2221–2227
- Schaub B, Liu J, Hoppler S, Haug S, Sattler C, Lluis A, Illi S, von Mutius E. Impairment of T-regulatory cells in cord blood of atopic mothers. J Allergy Clin Immunol. 2008; 121: 1491–1499, 1499 e1491–1413
- Amoudruz P, Holmlund U, Malmstrom V, Trollmo C, Bremme K, Scheynius A, Sverremark-Ekstrom E. Neonatal immune responses to microbial stimuli: is there an influence of maternal allergy? J Allergy Clin Immunol. 2005; 115: 1304–1310
- Eriksson NE, Mikoczy Z, Hagmar L. Cancer incidence in 13811 patients skin tested for allergy. J Investig Allergol Clin Immunol. 2005; 15: 161–166
- Ababou M. Bloom syndrome and the underlying causes of genetic instability. Mol Genet Metab. 2021; 133: 35–48
- Mushtaq N, Wali R, Fadoo Z, Saleem AF. Acute lymphoblastic leukemia in a child with Fanconi’s anaemia. J Coll Physicians Surg Pak. 2012; 22: 458–460
- Yetgin S, Tuncer M, Guler E, Duru F, Ali Kasifolu M. Acute lymphoblastic leukemia in Fanconi’s anemia. Am J Hematol. 1994; 45: 94
- Tischkowitz M, Dokal I. Fanconi anaemia and leukaemia - clinical and molecular aspects. Br J Haematol. 2004; 126: 176–191
- Schoenaker MHD, Henriet SS, Zonderland J, van Deuren M, Pan-Hammarstrom Q, Posthumus-van Sluijs SJ, Pico-Knijnenburg I, Weemaes CMR, H IJ. Immunodeficiency in Bloom’s Syndrome. J Clin Immunol. 2018; 38: 35–44
- Adams M, Jenney M, Lazarou L, White R, Birdsall S, Staab T, Schindler D, Meyer S. Acute myeloid leukaemia after treatment for acute lymphoblastic leukaemia in girl with Bloom syndrome. J Genet Syndr Gene Ther. 2013; 4:
- Roohi J, Crowe J, Loredan D, Anyane-Yeboa K, Mansukhani MM, Omesi L, Levine J, Revah Politi A, Zha S. New diagnosis of atypical ataxia-telangiectasia in a 17-year-old boy with T-cell acute lymphoblastic leukemia and a novel ATM mutation. J Hum Genet. 2017; 62: 581–584
- Liberzon E, Avigad S, Stark B, Zilberstein J, Freedman L, Gorfine M, Gavriel H, Cohen IJ, Goshen Y, Yaniv I, et al. Germ-line ATM gene alterations are associated with susceptibility to sporadic T-cell acute lymphoblastic leukemia in children. Genes Chromosomes Cancer. 2004; 39: 161–166
- Balgobind BV, Van Vlierberghe P, van den Ouweland AM, Beverloo HB, Terlouw-Kromosoeto JN, van Wering ER, Reinhardt D, Horstmann M, Kaspers GJ, Pieters R, et al. Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis. Blood. 2008; 111: 4322–4328
- Farah RA, Maalouf F, Chahine NA, Farhat H, Campbell B, Zhukova N, Durno C, Aronson M, Hawkins C, Bouffet E, et al. Ongoing issues with the management of children with Constitutional Mismatch Repair Deficiency syndrome. Eur J Med Genet. 2019; 62: 103706
- Ripperger T, Beger C, Rahner N, Sykora KW, Bockmeyer CL, Lehmann U, Kreipe HH, Schlegelberger B. Constitutional mismatch repair deficiency and childhood leukemia/lymphoma--report on a novel biallelic MSH6 mutation. Haematologica. 2010; 95: 841–844
- Schoemaker MJ, Jones ME, Higgins CD, Wright AF, United Kingdom Clinical Cytogenetics G, Swerdlow AJ. Mortality and Cancer Incidence in Carriers of Balanced Robertsonian Translocations: A National Cohort Study. Am J Epidemiol. 2019; 188: 500–508
- Harrison CJ, Schwab C. Constitutional abnormalities of chromosome 21 predispose to iAMP21-acute lymphoblastic leukaemia. Eur J Med Genet. 2016; 59: 162–165
- Coktu S, Spix C, Kaiser M, Beygo J, Kleinle S, Bachmann N, Kohlschmidt N, Prawitt D, Beckmann A, Klaes R, et al. Cancer incidence and spectrum among children with genetically confirmed Beckwith-Wiedemann spectrum in Germany: a retrospective cohort study. Br J Cancer. 2020; 123: 619–623
- Qian M, Cao X, Devidas M, Yang W, Cheng C, Dai Y, Carroll A, Heerema NA, Zhang H, Moriyama T, et al. TP53 Germline Variations Influence the Predisposition and Prognosis of B-Cell Acute Lymphoblastic Leukemia in Children J Clin Oncol. 2020; 36: 591–599
- Frebourg T, Bajalica Lagercrantz S, Oliveira C, Magenheim R, Evans DG. Guidelines for the Li-Fraumeni and heritable TP53-related cancer syndromes Eur J Hum Genet. 2020; 28: 1379–1386
- Rasmussen SA, Overman J, Thomson SA, Colman SD, Abernathy CR, Trimpert RE, Moose R, Virdi G, Roux K, Bauer M, et al. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1. Genes Chromosomes Cancer. 2000; 28: 425–431
- Pathak A, Pemov A, McMaster ML, Dewan R, Ravichandran S, Pak E, Dutra A, Lee HJ, Vogt A, Zhang X, et al. Juvenile myelomonocytic leukemia due to a germline CBL Y371C mutation: 35-year follow-up of a large family. Hum Genet. 2015; 134: 775–787
- Locatelli F, Niemeyer CM. How I treat juvenile myelomonocytic leukemia. Blood. 2015; 125: 1083–1090
- Schwartz JR, Ma J, Lamprecht T, Walsh M, Wang S, Bryant V, Song G, Wu G, Easton J, Kesserwan C, et al. The genomic landscape of pediatric myelodysplastic syndromes. Nat Commun. 2017; 8: 1557
- Wlodarski MW, Sahoo SS, Niemeyer CM. Monosomy 7 in Pediatric Myelodysplastic Syndromes. Hematol Oncol Clin North Am. 2018; 32: 729–743
- Palma-Barqueros V, Revilla N, Sanchez A, Zamora Canovas A, Rodriguez-Alen A, Marin-Quilez A, Gonzalez-Porras JR, Vicente V, Lozano ML, Bastida JM, et al. Inherited Platelet Disorders: An Updated Overview. Int J Mol Sci. 2021; 22:
- Warren JT, Di Paola J. Genetics of inherited thrombocytopenias. Blood. 2022; 139: 3264–3277
- Tawana K, Brown AL, Churpek JE. Integrating germline variant assessment into routine clinical practice for myelodysplastic syndrome and acute myeloid leukaemia: current strategies and challenges. Br J Haematol. 2022; 196: 1293–1310
- Farooqui SM, Ward R, Aziz M, Shwachman-Diamond Syndrome, in StatPearls. 2023: Treasure Island (FL).
- Bezzerri V, Cipolli M. Shwachman-Diamond Syndrome: Molecular Mechanisms and Current Perspectives. Mol Diagn Ther. 2019; 23: 281–290
- Dror Y, Donadieu J, Koglmeier J, Dodge J, Toiviainen-Salo S, Makitie O, Kerr E, Zeidler C, Shimamura A, Shah N, et al. Draft consensus guidelines for diagnosis and treatment of Shwachman-Diamond syndrome. Ann N Y Acad Sci. 2011; 1242: 40–55
- Bartels M, Bierings M. How I manage children with Diamond-Blackfan anaemia. Br J Haematol. 2019; 184: 123–133
- Ballmaier M, Germeshausen M. Congenital amegakaryocytic thrombocytopenia: clinical presentation, diagnosis, and treatment. Semin Thromb Hemost. 2011; 37: 673–681
- Shah A, Kumar C, Shanmukhaiah C, Rajendran A, Mudaliar S, Idicula-Thomas S, Vundinti BR. Genomic and computational analysis of four novel variants of MPL gene in Congenital Amegakaryocytic Thrombocytopenia. Ann Hematol. 2023; 102: 2683–2693
- Horwitz MS, Corey SJ, Grimes HL, Tidwell T. ELANE mutations in cyclic and severe congenital neutropenia: genetics and pathophysiology. Hematol Oncol Clin North Am. 2013; 27: 19–41, vii
- Connelly JA, Choi SW, Levine JE. Hematopoietic stem cell transplantation for severe congenital neutropenia. Curr Opin Hematol. 2012; 19: 44–51
- Skokowa J, Dale DC, Touw IP, Zeidler C, Welte K. Severe congenital neutropenias. Nat Rev Dis Primers. 2017; 3: 17032
- Simkins A, Maiti A, Short NJ, Jain N, Popat U, Patel KP, Oo TH. Acquired amegakaryocytic thrombocytopenia and red cell aplasia in a patient with thymoma progressing to aplastic anemia successfully treated with allogenic stem cell transplantation. Hematol Oncol Stem Cell Ther. 2019; 12: 115–118
- Maserati E, Panarello C, Morerio C, Valli R, Pressato B, Patitucci F, Tassano E, Di Cesare-Merlone A, Cugno C, Balduini CL, et al. Clonal chromosome anomalies and propensity to myeloid malignancies in congenital amegakaryocytic thrombocytopenia (OMIM 604498). Haematologica. 2008; 93: 1271–1273
- Agarwal N, Spahr JE, Werner TL, Newton DL, Rodgers GM. Acquired amegakaryocytic thrombocytopenic purpura. Am J Hematol. 2006; 81: 132–135
- Young NS. Aplastic Anemia. N Engl J Med. 2018; 379: 1643–1656
- Heuser M, Schlarmann C, Dobbernack V, Panagiota V, Wiehlmann L, Walter C, Beier F, Ziegler P, Yun H, Kade S, et al. Genetic characterization of acquired aplastic anemia by targeted sequencing. Haematologica. 2014; 99: e165–167
- Tichelli A, Schrezenmeier H, Socie G, Marsh J, Bacigalupo A, Duhrsen U, Franzke A, Hallek M, Thiel E, Wilhelm M, et al. A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the European Group for Blood and Marrow Transplantation. Blood. 2011; 117: 4434–4441
- Alter BP, Giri N, Savage SA, Rosenberg PS. Cancer in dyskeratosis congenita. Blood. 2009; 113: 6549–6557
- Kirschner M, Maurer A, Wlodarski MW, Ventura Ferreira MS, Bouillon AS, Halfmeyer I, Blau W, Kreuter M, Rosewich M, Corbacioglu S, et al. Recurrent somatic mutations are rare in patients with cryptic dyskeratosis congenita. Leukemia. 2018; 32: 1762–1767
- Ford AM, Ridge SA, Cabrera ME, Mahmoud H, Steel CM, Chan LC, Greaves M. In utero rearrangements in the trithorax-related oncogene in infant leukaemias. Nature. 1993; 363: 358–360
- Chuk MK, McIntyre E, Small D, Brown P. Discordance of MLL-rearranged (MLL-R) infant acute lymphoblastic leukemia in monozygotic twins with spontaneous clearance of preleukemic clone in unaffected twin. Blood. 2009; 113: 6691–6694
- Hunger SP, Mullighan CG. Acute Lymphoblastic Leukemia in Children. N Engl J Med. 2015; 373: 1541–1552
- Caughey RW, Michels KB. Birth weight and childhood leukemia: a meta-analysis and review of the current evidence. Int J Cancer. 2009; 124: 2658–2670
- Kwan ML, Jensen CD, Block G, Hudes ML, Chu LW, Buffler PA. Maternal diet and risk of childhood acute lymphoblastic leukemia. Public Health Rep. 2009; 124: 503–514
- World Health Organization. Daily iron and folic acid supplementation in pregnant women. 2020; Available from:
http://apps.who.int/iris/bitstream/handle/10665/77770/9789241501996_eng.pdf . - Metayer C, Milne E, Dockerty JD, Clavel J, Pombo-de-Oliveira MS, Wesseling C, Spector LG, Schuz J, Petridou E, Ezzat S, et al. Maternal supplementation with folic acid and other vitamins and risk of leukemia in offspring: a Childhood Leukemia International Consortium study. Epidemiology. 2014; 25: 811–822
- Milne E, Royle JA, Miller M, Bower C, de Klerk NH, Bailey HD, van Bockxmeer F, Attia J, Scott RJ, Norris MD, et al. Maternal folate and other vitamin supplementation during pregnancy and risk of acute lymphoblastic leukemia in the offspring. Int J Cancer. 2010; 126: 2690–2699
- Wilson RD, O’Connor DL. Maternal folic acid and multivitamin supplementation: International clinical evidence with considerations for the prevention of folate-sensitive birth defects. Prev Med Rep. 2021; 24: 101617
- Lokossou GAG, Kouakanou L, Schumacher A, Zenclussen AC. Human Breast Milk: From Food to Active Immune Response With Disease Protection in Infants and Mothers. Front Immunol. 2022; 13: 849012
- Walker WA, Iyengar RS. Breast milk, microbiota, and intestinal immune homeostasis. Pediatr Res. 2015; 77: 220–228
- Gong QQ, Quan DD, Guo C, Zhang C, Zhang ZJ. Association between maternal breastfeeding and risk of systemic neoplasms of offspring. Ital J Pediatr. 2022; 48: 98
- Amitay EL, Keinan-Boker L. Breastfeeding and Childhood Leukemia Incidence--Reply. JAMA Pediatr. 2015; 169: 1071–1072
- Turner MC, Wigle DT, Krewski D. Residential pesticides and childhood leukemia: a systematic review and meta-analysis. Environ Health Perspect. 2009; 118: 33–41
- Brondum J, Shu XO, Steinbuch M, Severson RK, Potter JD, Robison LL. Parental cigarette smoking and the risk of acute leukemia in children. Cancer. 1999; 85: 1380–1388
- Shu XO, Ross JA, Pendergrass TW, Reaman GH, Lampkin B, Robison LL. Parental alcohol consumption, cigarette smoking, and risk of infant leukemia: a Childrens Cancer Group study. J Natl Cancer Inst. 1996; 88: 24–31
- Ognjanovic S, Blair C, Spector LG, Robison LL, Roesler M, Ross JA. Analgesic use during pregnancy and risk of infant leukaemia: a Children’s Oncology Group study. Br J Cancer. 2011; 104: 532–536
- Momen NC, Munk-Olsen T, Li J, Ingstrup KG, Olsen J, Bergink V, Liu X. Antidepressant use during pregnancy and childhood cancer in the offspring. Pharmacoepidemiol Drug Saf. 2018; 27: 114–118
- Behjati S, Gundem G, Wedge DC, Roberts ND, Tarpey PS, Cooke SL, Van Loo P, Alexandrov LB, Ramakrishna M, Davies H, et al. Mutational signatures of ionizing radiation in second malignancies. Nat Commun. 2016; 7: 12605
- Nikkila A, Raitanen J, Lohi O, Auvinen A. Radiation exposure from computerized tomography and risk of childhood leukemia: Finnish register-based case-control study of childhood leukemia (FRECCLE). Haematologica. 2018; 103: 1873–1880
- Doll R, Wakeford R. Risk of childhood cancer from fetal irradiation. Br J Radiol. 1997; 70: 130–139
- Nottage K, Lanctot J, Li Z, Neglia JP, Bhatia S, Hammond S, Leisenring W, Meadows A, Srivastava D, Robison LL, et al. Long-term risk for subsequent leukemia after treatment for childhood cancer: a report from the Childhood Cancer Survivor Study. Blood. 2011; 117: 6315–6318
- Naoe T, Takeyama K, Yokozawa T, Kiyoi H, Seto M, Uike N, Ino T, Utsunomiya A, Maruta A, Jin-nai I, et al. Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia/myelodysplastic syndrome and de novo acute myeloid leukemia. Clin Cancer Res. 2000; 6: 4091–4095
- Ron E, Modan B, Boice JD, Jr. Mortality after radiotherapy for ringworm of the scalp. Am J Epidemiol. 1988; 127: 713–725
- Lundell M, Holm LE. Mortality from leukemia after irradiation in infancy for skin hemangioma. Radiat Res. 1996; 145: 595–601
- Kheifets L, Repacholi M, Saunders R, van Deventer E. The sensitivity of children to electromagnetic fields. Pediatrics. 2005; 116: e303–313
- Schuz J, Philipp J, Merzenich H, Schmiedel S, Bruggemeyer H. Re: “Radio-frequency radiation exposure from AM radio transmitters and childhood leukemia and brain cancer”. Am J Epidemiol. 2008; 167: 883–884
- Repacholi M, Saunders R, van Deventer E, Kheifets L. Guest editors’ introduction: is EMF a potential environmental risk for children? Bioelectromagnetics. 2005; Suppl 7: S2–4
- Hijiya N, Ness KK, Ribeiro RC, Hudson MM. Acute leukemia as a secondary malignancy in children and adolescents: current findings and issues. Cancer. 2009; 115: 23–35
- Hawkins MM, Wilson LM, Stovall MA, Marsden HB, Potok MH, Kingston JE, Chessells JM. Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer. BMJ. 1992; 304: 951–958
- Le Deley MC, Leblanc T, Shamsaldin A, Raquin MA, Lacour B, Sommelet D, Chompret A, Cayuela JM, Bayle C, Bernheim A, et al. Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: a case-control study by the Societe Francaise d’Oncologie Pediatrique. J Clin Oncol. 2003; 21: 1074–1081